TICKERNOMICS Sign up
Last Update: 2024-12-27 15:30:05
Aditxt Inc. ( ADTX ) https://www.aditxt.com
0.19USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-99.90%
ADTX
SPY
32.66%
-99.14%
ADTX
SPY
108.59%
ADTX
0.00%
SPY
302.52%
ADTX
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
0.02
0.96
10.70
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.00
0.10
0.00
-118.27
0.00
-0.04
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-68588.24
-6721.36
-19114.46
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.32
-177.85
-208.79
0.00
Other Earnings and Cash Flow Stats:
Aditxt Inc. ( ADTX ) Net Income TTM ($MM) is -46.10
Aditxt Inc. ( ADTX ) Operating Income TTM ($MM) is -30.16
Aditxt Inc. ( ADTX ) Owners' Earnings Annual ($MM) is 0.00
Aditxt Inc. ( ADTX ) Current Price to Owners' Earnings ratio is 0.00
Aditxt Inc. ( ADTX ) EBITDA TTM ($MM) is -29.58
Aditxt Inc. ( ADTX ) EBITDA Margin is -19114.46%
Capital Allocation:
Aditxt Inc. ( ADTX ) has paid 0.00 dividends per share and bought back 0.087575 million shares in the past 12 months
Aditxt Inc. ( ADTX ) has reduced its debt by 1.014643 million USD in the last 12 months
Capital Structure:
Aditxt Inc. ( ADTX ) Interest-bearing Debt ($MM) as of last quarter is 1
Aditxt Inc. ( ADTX ) Annual Working Capital Investments ($MM) are -14
Aditxt Inc. ( ADTX ) Book Value ($MM) as of last quarter is 4
Aditxt Inc. ( ADTX ) Debt/Capital as of last quarter is 26%
Other Balance Sheet Stats:
Aditxt Inc. ( ADTX ) has 0 million in cash on hand as of last quarter
Aditxt Inc. ( ADTX ) has 24 million of liabilities due within 12 months, and long term debt 6 as of last quarter
Aditxt Inc. ( ADTX ) has 0 common shares outstanding as of last quarter
Aditxt Inc. ( ADTX ) has 0 million USD of preferred stock value
Academic Scores:
Aditxt Inc. ( ADTX ) Altman Z-Score is -11.51 as of last quarter
Aditxt Inc. ( ADTX ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
Aditxt Inc. ( ADTX ) largest shareholder is Federation des caisses Desjardins du Quebec owning 500 shares at 0.00 ($MM) value
HRT FINANCIAL LP(an insider) Sold 25534 shares of Aditxt Inc. ( ADTX ) for the amount of $29874.78 on 2024-10-16
0.01% of Aditxt Inc. ( ADTX ) is held by insiders, and 0.25% is held by institutions
Aditxt Inc. ( ADTX ) went public on 2020-06-30
Other Aditxt Inc. ( ADTX ) financial metrics:
FCF:-13.93
Unlevered Free Cash Flow:0.00
EPS:-11.11
Operating Margin:-68588.24
Gross Profit Margin:-6721.36
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-1090.69
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Aditxt Inc. ( ADTX ) :
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.